Patricia Zilliox

Patricia Zilliox, Ph.D. in Pharmacy, managed the ophthalmology clinical development programs as Senior Director Clinical Pharma at Alcon Laboratories in the US until 2011. Most recently, Patricia was responsible for identifying, funding and developing promising treatments for gene mutated retinal diseases at the Clinical Research Institute, a division of the Foundation Fighting Blindness, in Columbia, Maryland. Since 2017, she has been President and CEO of Eyevensys, a biotech company developing a non-viral gene therapy platform for the treatment of retinal diseases.